Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination

•LAIV3 induced age-related hemagglutination inhibition antibody responses.•IgG1 was the main IgG subclass detected followed by IgG3.•Significant hemagglutinin-specific IgG1 and IgA1 response in children but not adults.•LAIV3 and IIV3 induced IgG antibodies with comparable and significantly increased...

Full description

Saved in:
Bibliographic Details
Published inVaccine Vol. 35; no. 1; pp. 191 - 198
Main Authors Manenti, Alessandro, Tete, Sarah M., Mohn, Kristin G.-I., Jul-Larsen, Åsne, Gianchecchi, Elena, Montomoli, Emanuele, Brokstad, Karl A., Cox, Rebecca J.
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 03.01.2017
Elsevier Limited
Subjects
Online AccessGet full text
ISSN0264-410X
1873-2518
DOI10.1016/j.vaccine.2016.10.024

Cover

Abstract •LAIV3 induced age-related hemagglutination inhibition antibody responses.•IgG1 was the main IgG subclass detected followed by IgG3.•Significant hemagglutinin-specific IgG1 and IgA1 response in children but not adults.•LAIV3 and IIV3 induced IgG antibodies with comparable and significantly increased avidity. Two different influenza vaccines are generally used in many countries; trivalent live attenuated influenza vaccine (LAIV3) and trivalent inactivated influenza vaccine (IIV3). Studies comparing the antibody response to IIV3 and LAIV3 commonly investigate the seroprotective response by hemagglutination-inhibition (HI) assay. However, there is limited data regarding comparative analysis of IgG subclass and IgA responses induced by LAIV3 and IIV3. Fifteen children <5years received 2 doses of LAIV3 while 14 children aged 10–17years received one dose. In addition, 15 adults were vaccinated with either intranasal LAIV3 or intramuscular IIV3. We analyzed the H3N2 humoral responses by HI assay and the hemagglutinin (HA) specific IgG1, IgG2, IgG3, IgG4 and IgA1 responses by ELISA. Furthermore, we investigated the avidity of induced IgG antibodies. Pre-existing seroprotective HI antibodies were present in adults (73%) previously vaccinated with IIV3. Vaccination resulted in a significant increase in HI titers in all groups, except LAIV3 vaccinated adults. Furthermore, a negative correlation between age and HI titers in LAIV3 vaccinated subjects was observed post-vaccination. LAIV3 in children and IIV3 in adults induced HA-specific IgG1, low IgG3 but no IgG2 or IgG4. Moreover, significant IgA1 responses were only induced in children. Interestingly, IIV3 and LAIV3 induced IgG antibodies with comparable and significantly augmented avidity post-vaccination in children and adults. Our results suggest that age and/or exposure history play a significant role in determining the antibody response. Clinical trial registry: ClinicalTrials.gov NCT01003288 and NCT01866540
AbstractList Two different influenza vaccines are generally used in many countries; trivalent live attenuated influenza vaccine (LAIV3) and trivalent inactivated influenza vaccine (IIV3). Studies comparing the antibody response to IIV3 and LAIV3 commonly investigate the seroprotective response by hemagglutination-inhibition (HI) assay. However, there is limited data regarding comparative analysis of IgG subclass and IgA responses induced by LAIV3 and IIV3.Fifteen children <5years received 2 doses of LAIV3 while 14 children aged 10–17years received one dose. In addition, 15 adults were vaccinated with either intranasal LAIV3 or intramuscular IIV3. We analyzed the H3N2 humoral responses by HI assay and the hemagglutinin (HA) specific IgG1, IgG2, IgG3, IgG4 and IgA1 responses by ELISA. Furthermore, we investigated the avidity of induced IgG antibodies.Pre-existing seroprotective HI antibodies were present in adults (73%) previously vaccinated with IIV3. Vaccination resulted in a significant increase in HI titers in all groups, except LAIV3 vaccinated adults. Furthermore, a negative correlation between age and HI titers in LAIV3 vaccinated subjects was observed post-vaccination. LAIV3 in children and IIV3 in adults induced HA-specific IgG1, low IgG3 but no IgG2 or IgG4. Moreover, significant IgA1 responses were only induced in children. Interestingly, IIV3 and LAIV3 induced IgG antibodies with comparable and significantly augmented avidity post-vaccination in children and adults.Our results suggest that age and/or exposure history play a significant role in determining the antibody response.Clinical trial registry: ClinicalTrials.gov NCT01003288 and NCT01866540
Two different influenza vaccines are generally used in many countries; trivalent live attenuated influenza vaccine (LAIV3) and trivalent inactivated influenza vaccine (IIV3). Studies comparing the antibody response to IIV3 and LAIV3 commonly investigate the seroprotective response by hemagglutination-inhibition (HI) assay. However, there is limited data regarding comparative analysis of IgG subclass and IgA responses induced by LAIV3 and IIV3. Fifteen children <5years received 2 doses of LAIV3 while 14 children aged 10-17years received one dose. In addition, 15 adults were vaccinated with either intranasal LAIV3 or intramuscular IIV3. We analyzed the H3N2 humoral responses by HI assay and the hemagglutinin (HA) specific IgG1, IgG2, IgG3, IgG4 and IgA1 responses by ELISA. Furthermore, we investigated the avidity of induced IgG antibodies. Pre-existing seroprotective HI antibodies were present in adults (73%) previously vaccinated with IIV3. Vaccination resulted in a significant increase in HI titers in all groups, except LAIV3 vaccinated adults. Furthermore, a negative correlation between age and HI titers in LAIV3 vaccinated subjects was observed post-vaccination. LAIV3 in children and IIV3 in adults induced HA-specific IgG1, low IgG3 but no IgG2 or IgG4. Moreover, significant IgA1 responses were only induced in children. Interestingly, IIV3 and LAIV3 induced IgG antibodies with comparable and significantly augmented avidity post-vaccination in children and adults. Our results suggest that age and/or exposure history play a significant role in determining the antibody response. Clinical trial registry: ClinicalTrials.gov NCT01003288 and NCT01866540.
•LAIV3 induced age-related hemagglutination inhibition antibody responses.•IgG1 was the main IgG subclass detected followed by IgG3.•Significant hemagglutinin-specific IgG1 and IgA1 response in children but not adults.•LAIV3 and IIV3 induced IgG antibodies with comparable and significantly increased avidity. Two different influenza vaccines are generally used in many countries; trivalent live attenuated influenza vaccine (LAIV3) and trivalent inactivated influenza vaccine (IIV3). Studies comparing the antibody response to IIV3 and LAIV3 commonly investigate the seroprotective response by hemagglutination-inhibition (HI) assay. However, there is limited data regarding comparative analysis of IgG subclass and IgA responses induced by LAIV3 and IIV3. Fifteen children <5years received 2 doses of LAIV3 while 14 children aged 10–17years received one dose. In addition, 15 adults were vaccinated with either intranasal LAIV3 or intramuscular IIV3. We analyzed the H3N2 humoral responses by HI assay and the hemagglutinin (HA) specific IgG1, IgG2, IgG3, IgG4 and IgA1 responses by ELISA. Furthermore, we investigated the avidity of induced IgG antibodies. Pre-existing seroprotective HI antibodies were present in adults (73%) previously vaccinated with IIV3. Vaccination resulted in a significant increase in HI titers in all groups, except LAIV3 vaccinated adults. Furthermore, a negative correlation between age and HI titers in LAIV3 vaccinated subjects was observed post-vaccination. LAIV3 in children and IIV3 in adults induced HA-specific IgG1, low IgG3 but no IgG2 or IgG4. Moreover, significant IgA1 responses were only induced in children. Interestingly, IIV3 and LAIV3 induced IgG antibodies with comparable and significantly augmented avidity post-vaccination in children and adults. Our results suggest that age and/or exposure history play a significant role in determining the antibody response. Clinical trial registry: ClinicalTrials.gov NCT01003288 and NCT01866540
Highlights • LAIV3 induced age-related hemagglutination inhibition antibody responses. • IgG1 was the main IgG subclass detected followed by IgG3. • Significant hemagglutinin-specific IgG1 and IgA1 response in children but not adults. • LAIV3 and IIV3 induced IgG antibodies with comparable and significantly increased avidity.
Author Manenti, Alessandro
Cox, Rebecca J.
Tete, Sarah M.
Mohn, Kristin G.-I.
Brokstad, Karl A.
Gianchecchi, Elena
Jul-Larsen, Åsne
Montomoli, Emanuele
Author_xml – sequence: 1
  givenname: Alessandro
  surname: Manenti
  fullname: Manenti, Alessandro
  organization: Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy
– sequence: 2
  givenname: Sarah M.
  surname: Tete
  fullname: Tete, Sarah M.
  email: sarah.tete@uib.no
  organization: The Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway
– sequence: 3
  givenname: Kristin G.-I.
  surname: Mohn
  fullname: Mohn, Kristin G.-I.
  organization: The Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway
– sequence: 4
  givenname: Åsne
  surname: Jul-Larsen
  fullname: Jul-Larsen, Åsne
  organization: The Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway
– sequence: 5
  givenname: Elena
  surname: Gianchecchi
  fullname: Gianchecchi, Elena
  organization: VisMederi Srl, Siena, Italy
– sequence: 6
  givenname: Emanuele
  surname: Montomoli
  fullname: Montomoli, Emanuele
  organization: Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy
– sequence: 7
  givenname: Karl A.
  surname: Brokstad
  fullname: Brokstad, Karl A.
  organization: Broegelman Research Laboratory, Department of Clinical Sciences, University of Bergen, Bergen, Norway
– sequence: 8
  givenname: Rebecca J.
  surname: Cox
  fullname: Cox, Rebecca J.
  email: rebecca.cox@uib.no
  organization: The Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27789145$$D View this record in MEDLINE/PubMed
BookMark eNqNklFv0zAQxy00xLrCRwBZ4mU8pNhO7CRCA1UVbJMmeAAk3izHuXQurhPspFL3SfZxcdZOoEqoPFk-_-5_57v_GTpxrQOEXlIyo4SKt6vZRmltHMxYvMbYjLDsCZrQIk8TxmlxgiaEiSzJKPlxis5CWBFCeErLZ-iU5XlR0oxP0P2iXXfKq95sACun7DaYgNsGG9fYAdydwvPzq_Qze4M3xg8B38JaLZd26I0zDocOtGmMxtfLSxyGSlsVQtSpY2COPYSudQFCVMP61tjag3t4VfVg-wg2Pfi_Su2-FJtp3XP0tFE2wIv9OUXfP338trhKbr5cXi_mN4kWlPcJF7WqqiZLC100RBFBFGM6z1Utilo0vCqzQnDOYrDUFeM54UwzylSjhVClSqfofKfb-fbXAKGXaxM0WKsctEOQLE6NcZby_ChKSyIyXgqRHUeLlIu4gWJEXx-gq3bwcRMjlYmCsjLSU_RqTw3VGmrZebNWfisfNxmBdztA-zYED43Upn-YZO-VsZISOfpGruTeN3L0zRiOvonZ_CD7scCxvA-7PIgr2hjwMmgDTkNtPOhe1q05qvD-QEHbaC2t7E_YQvgzCxmYJPLr6OnR0lSkpMxIGQUu_i3wHw38BgMYCT8
CitedBy_id crossref_primary_10_3201_eid2502_180359
crossref_primary_10_1093_jpids_piad033
crossref_primary_10_1371_journal_pone_0244157
crossref_primary_10_1021_acs_jproteome_1c00913
crossref_primary_10_1073_pnas_2216521120
crossref_primary_10_1038_s41598_022_18977_0
crossref_primary_10_1080_14760584_2020_1711056
crossref_primary_10_3390_vaccines9090998
crossref_primary_10_1016_j_jim_2020_112937
crossref_primary_10_1371_journal_pone_0247253
crossref_primary_10_1093_cid_ciz774
crossref_primary_10_1097_MOP_0000000000001438
crossref_primary_10_1002_cti2_1456
crossref_primary_10_1016_j_antiviral_2024_105823
crossref_primary_10_1111_irv_12664
crossref_primary_10_1128_mBio_02281_16
crossref_primary_10_1016_j_vaccine_2021_12_034
crossref_primary_10_1016_j_vaccine_2017_08_044
crossref_primary_10_1038_s41577_019_0143_6
crossref_primary_10_15789_1563_0625_AOT_2737
crossref_primary_10_1155_2022_4813199
crossref_primary_10_4049_jimmunol_2400326
Cites_doi 10.1007/s10875-010-9501-7
10.1093/infdis/154.1.121
10.1086/515656
10.1016/j.jim.2015.04.009
10.1016/j.vaccine.2010.10.038
10.1086/315003
10.1146/annurev.biochem.69.1.531
10.1097/01.inf.0000237829.66310.85
10.1093/infdis/jit207
10.1371/journal.ppat.1004940
10.1016/S0264-410X(99)00334-5
10.1016/j.cyto.2012.08.004
10.1093/cid/cit736
10.1099/0022-1317-82-6-1387
10.1016/j.vaccine.2008.07.013
10.1016/j.vaccine.2015.05.081
10.1016/j.vaccine.2012.09.018
10.1016/S0264-410X(00)00171-7
10.1016/j.jaci.2009.09.046
10.1086/517407
10.1016/S1386-6532(01)00246-3
10.1128/IAI.40.3.1044-1051.1983
10.1016/j.vaccine.2014.06.009
10.1016/j.vaccine.2005.08.105
10.1128/JCM.23.1.66-72.1986
10.1128/JCM.24.1.157-160.1986
10.1016/S0022-3476(00)70097-7
10.1186/1742-4933-10-14
10.4049/jimmunol.178.2.1030
10.1093/infdis/171.1.198
10.1586/eri.11.51
10.1016/j.vaccine.2007.02.039
10.1093/infdis/jis641
10.1111/j.1365-2249.2011.04550.x
10.1097/01.inf.0000237797.14283.cf
10.7883/yoken.JJID.2004.236
10.1111/ajt.13065
ContentType Journal Article
Copyright 2016 The Authors
The Authors
Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.
Copyright Elsevier Limited Jan 3, 2017
Copyright_xml – notice: 2016 The Authors
– notice: The Authors
– notice: Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.
– notice: Copyright Elsevier Limited Jan 3, 2017
DBID 6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QL
7RV
7T2
7T5
7U9
7X7
7XB
88C
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
H94
HCIFZ
K9-
K9.
KB0
LK8
M0R
M0S
M0T
M1P
M2O
M7N
M7P
MBDVC
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
7S9
L.6
DOI 10.1016/j.vaccine.2016.10.024
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Nursing & Allied Health Database
Health and Safety Science Abstracts (Full archive)
Immunology Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Healthcare Administration Database (Alumni)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
AIDS and Cancer Research Abstracts
SciTech Collection (ProQuest)
Consumer Health Database (Alumni Edition)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Biological Sciences
ProQuest Consumer Health Database
ProQuest Health & Medical Collection
Healthcare Administration Database
Medical Database
ProQuest Research Library
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Research Library Prep
ProQuest Central Student
ProQuest Central Essentials
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest Health Management (Alumni Edition)
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Family Health (Alumni Edition)
ProQuest Central
ProQuest Health & Medical Research Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
ProQuest Research Library
Health & Safety Science Abstracts
ProQuest Public Health
ProQuest Central Basic
ProQuest Health Management
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
ProQuest Medical Library
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList AGRICOLA
AIDS and Cancer Research Abstracts
MEDLINE - Academic


MEDLINE

Research Library Prep
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Veterinary Medicine
Biology
Pharmacy, Therapeutics, & Pharmacology
EISSN 1873-2518
EndPage 198
ExternalDocumentID 4272457301
27789145
10_1016_j_vaccine_2016_10_024
S0264410X16309409
1_s2_0_S0264410X16309409
Genre Research Support, Non-U.S. Gov't
Journal Article
Comparative Study
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
123
1B1
1P~
1RT
1~.
1~5
4.4
457
4G.
53G
5RE
5VS
7-5
71M
7RV
7X7
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8G5
8P~
9JM
AAAJQ
AABNK
AAEDT
AAEDW
AAHBH
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AARKO
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABFRF
ABJNI
ABKYH
ABMAC
ABMZM
ABRWV
ABUWG
ACDAQ
ACGFO
ACGFS
ACIEU
ACIUM
ACPRK
ACRLP
ACVFH
ADBBV
ADCNI
ADEZE
ADFRT
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEUYN
AEVXI
AEXOQ
AFKRA
AFPUW
AFRAH
AFRHN
AFTJW
AFXIZ
AGCQF
AGEKW
AGGSO
AGUBO
AGYEJ
AHMBA
AIEXJ
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
AQUVI
AXJTR
AZQEC
BBNVY
BENPR
BHPHI
BKEYQ
BKNYI
BKOJK
BLXMC
BNPGV
BPHCQ
BVXVI
CCPQU
CJTIS
CNWQP
CS3
DWQXO
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FNPLU
FYGXN
FYUFA
G-Q
GBLVA
GNUQQ
GUQSH
HCIFZ
HMCUK
IHE
J1W
K9-
KOM
L7B
LK8
LUGTX
LW9
M0R
M0T
M1P
M29
M2O
M41
M7P
MO0
N9A
NAPCQ
O-L
O9-
O9~
OAUVE
OK0
OZT
P-8
P-9
P2P
PC.
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
PUEGO
Q38
ROL
RPZ
SAB
SCC
SDF
SDG
SDP
SES
SNL
SPCBC
SSH
SSI
SSZ
T5K
UKHRP
UV1
WH7
WOW
Z5R
~G-
.GJ
29Q
3V.
AACTN
AAQXK
ABWVN
ABXDB
ACRPL
ADMUD
ADNMO
ADVLN
AFCTW
AFJKZ
AFKWA
AGHFR
AHHHB
AJOXV
ALIPV
AMFUW
ASPBG
AVWKF
AZFZN
FEDTE
FGOYB
G-2
HEJ
HLV
HMG
HMK
HMO
HVGLF
HX~
HZ~
R2-
RIG
SAE
SEW
SIN
SVS
WUQ
XPP
ZGI
ZXP
6I.
AAFTH
AAIAV
ABLVK
ABYKQ
AESVU
AJBFU
EFLBG
LCYCR
QYZTP
AAYXX
ACMHX
ADSLC
AGQPQ
AGRNS
AGWPP
AIGII
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7T2
7T5
7U9
7XB
8FK
C1K
H94
K9.
M7N
MBDVC
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
7S9
L.6
ID FETCH-LOGICAL-c615t-56dabbf438c8f0a060a22c77ad68d6f5b948655222c9cb257052c212afc66a9a3
IEDL.DBID AIKHN
ISSN 0264-410X
IngestDate Fri Sep 05 09:58:19 EDT 2025
Fri Sep 05 03:47:44 EDT 2025
Thu Sep 04 17:33:10 EDT 2025
Wed Aug 13 09:21:19 EDT 2025
Thu Apr 03 07:01:22 EDT 2025
Tue Jul 01 01:06:32 EDT 2025
Thu Apr 24 22:58:48 EDT 2025
Fri Feb 23 02:21:13 EST 2024
Tue Feb 25 20:08:49 EST 2025
Tue Aug 26 16:38:07 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Live attenuated influenza vaccine
IgA
LAIV3
Influenza
IgG subclass
Antibody response
Language English
License This is an open access article under the CC BY-NC-ND license.
Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c615t-56dabbf438c8f0a060a22c77ad68d6f5b948655222c9cb257052c212afc66a9a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S0264410X16309409
PMID 27789145
PQID 1846812918
PQPubID 105530
PageCount 8
ParticipantIDs proquest_miscellaneous_2000252357
proquest_miscellaneous_1906459664
proquest_miscellaneous_1835691484
proquest_journals_1846812918
pubmed_primary_27789145
crossref_citationtrail_10_1016_j_vaccine_2016_10_024
crossref_primary_10_1016_j_vaccine_2016_10_024
elsevier_sciencedirect_doi_10_1016_j_vaccine_2016_10_024
elsevier_clinicalkeyesjournals_1_s2_0_S0264410X16309409
elsevier_clinicalkey_doi_10_1016_j_vaccine_2016_10_024
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-01-03
PublicationDateYYYYMMDD 2017-01-03
PublicationDate_xml – month: 01
  year: 2017
  text: 2017-01-03
  day: 03
PublicationDecade 2010
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
– name: Kidlington
PublicationTitle Vaccine
PublicationTitleAlternate Vaccine
PublicationYear 2017
Publisher Elsevier Ltd
Elsevier Limited
Publisher_xml – name: Elsevier Ltd
– name: Elsevier Limited
References Pedersen, Hoschler, Oie Solbak, Bredholt, Pathirana, Afsar (b0085) 2014; 32
Organization WH. Influenza (seasonal) factsheet 211; 2014. Available from
Edwards, Dimmock (b0105) 2001; 82
Boyce, Hsu, Sannella, Coleman-Dockery, Baylis, Zhu (b0175) 2000; 19
Johnson, Feldman, Thompson, Mahoney, Wright (b0185) 1986; 154
Clements, O’Donnell, Levine, Chanock, Murphy (b0095) 1983; 40
El-Madhun, Cox, Haaheim (b0070) 1999; 180
Belshe, Gruber, Mendelman, Cho, Reisinger, Block (b0155) 2000; 136
Goodwin, Viboud, Simonsen (b0020) 2006; 24
Powell, Strutt, Reome, Hollenbaugh, Roberts, Woodland (b0140) 2007; 178
Katz, Hancock, Xu (b0035) 2011; 9
Stepanova, Naykhin, Kolmskog, Jonson, Barantceva, Bichurina (b0115) 2002; 24
Fleming, Crovari, Wahn, Klemola, Schlesinger, Langussis (b0130) 2006; 25
Ambrose, Wu, Jones, Mallory (b0150) 2012; 30
Treanor, Kotloff, Betts, Belshe, Newman, Iacuzio (b0135) 1999; 18
Clements, Murphy (b0100) 1986; 23
Clements, Betts, Tierney, Murphy (b0055) 1986 Jul; 24
Ramakrishnan, Althoff, Lopez, Coles, Bream (b0010) 2012; 60
Frasca, Blomberg (b0120) 2011; 31
Tamura, Kurata (b0075) 2004; 57
Ohmit, Thompson, Petrie, Thaker, Jackson, Belongia (b0025) 2014; 58
Barria, Garrido, Stein, Scher, Ge, Engel (b0180) 2013; 207
Schild, Pereira, Chakraverty (b0040) 1975; 52
el-Madhun, Cox, Soreide, Olofsson, Haaheim (b0170) 1998; 178
.
Mohn, Bredholt, Brokstad, Pathirana, Aarstad, Tondel (b0190) 2014; 25
Frasca, Diaz, Romero, Mendez, Landin, Blomberg (b0030) 2013; 10
Skehel, Wiley (b0110) 2000; 69
Goldblatt, Vaz, Miller (b0195) 1998 Apr; 177
Schroeder, Cavacini (b0065) 2010; 125
Ashkenazi, Vertruyen, Aristegui, Esposito, McKeith, Klemola (b0125) 2006; 25
Block, Yogev, Hayden, Ambrose, Zeng, Walker (b0160) 2008; 26
Eidem, Tete, Jul-Larsen, Hoschler, Montomoli, Brokstad (b0200) 2015; 33
Crum-Cianflone, Collins, Defang, Iverson, Eberly, Duplessis (b0060) 2012; 168
Grohskopf, Olsen, Sokolow, Bresee, Cox, Broder (b0090) 2014; 14
Meyer, Wilke (b0005) 2015; 11
Brokstad, Cox, Olofsson, Jonsson, Haaheim (b0165) 1995; 171
Trombetta, Perini, Vitale, Cox, Stanzani, Piccirella (b0045) 2015; 422
Cheng, Zengel, Suguitan, Xu, Wang, Lin (b0145) 2013; 208
Stephenson, Das, Wood, Katz (b0050) 2007; 25
Madhun, Akselsen, Sjursen, Pedersen, Svindland, Nostbakken (b0080) 2010; 29
Johnson (10.1016/j.vaccine.2016.10.024_b0185) 1986; 154
Clements (10.1016/j.vaccine.2016.10.024_b0055) 1986; 24
Belshe (10.1016/j.vaccine.2016.10.024_b0155) 2000; 136
Eidem (10.1016/j.vaccine.2016.10.024_b0200) 2015; 33
Brokstad (10.1016/j.vaccine.2016.10.024_b0165) 1995; 171
Barria (10.1016/j.vaccine.2016.10.024_b0180) 2013; 207
Frasca (10.1016/j.vaccine.2016.10.024_b0030) 2013; 10
Ashkenazi (10.1016/j.vaccine.2016.10.024_b0125) 2006; 25
Clements (10.1016/j.vaccine.2016.10.024_b0100) 1986; 23
Stephenson (10.1016/j.vaccine.2016.10.024_b0050) 2007; 25
Madhun (10.1016/j.vaccine.2016.10.024_b0080) 2010; 29
Ramakrishnan (10.1016/j.vaccine.2016.10.024_b0010) 2012; 60
Frasca (10.1016/j.vaccine.2016.10.024_b0120) 2011; 31
Meyer (10.1016/j.vaccine.2016.10.024_b0005) 2015; 11
Tamura (10.1016/j.vaccine.2016.10.024_b0075) 2004; 57
Ohmit (10.1016/j.vaccine.2016.10.024_b0025) 2014; 58
Mohn (10.1016/j.vaccine.2016.10.024_b0190) 2014; 25
Trombetta (10.1016/j.vaccine.2016.10.024_b0045) 2015; 422
Pedersen (10.1016/j.vaccine.2016.10.024_b0085) 2014; 32
Grohskopf (10.1016/j.vaccine.2016.10.024_b0090) 2014; 14
Boyce (10.1016/j.vaccine.2016.10.024_b0175) 2000; 19
Goodwin (10.1016/j.vaccine.2016.10.024_b0020) 2006; 24
Cheng (10.1016/j.vaccine.2016.10.024_b0145) 2013; 208
Treanor (10.1016/j.vaccine.2016.10.024_b0135) 1999; 18
Powell (10.1016/j.vaccine.2016.10.024_b0140) 2007; 178
Ambrose (10.1016/j.vaccine.2016.10.024_b0150) 2012; 30
Block (10.1016/j.vaccine.2016.10.024_b0160) 2008; 26
Schroeder (10.1016/j.vaccine.2016.10.024_b0065) 2010; 125
Katz (10.1016/j.vaccine.2016.10.024_b0035) 2011; 9
Crum-Cianflone (10.1016/j.vaccine.2016.10.024_b0060) 2012; 168
Edwards (10.1016/j.vaccine.2016.10.024_b0105) 2001; 82
El-Madhun (10.1016/j.vaccine.2016.10.024_b0070) 1999; 180
10.1016/j.vaccine.2016.10.024_b0015
Goldblatt (10.1016/j.vaccine.2016.10.024_b0195) 1998; 177
Clements (10.1016/j.vaccine.2016.10.024_b0095) 1983; 40
Skehel (10.1016/j.vaccine.2016.10.024_b0110) 2000; 69
Schild (10.1016/j.vaccine.2016.10.024_b0040) 1975; 52
Stepanova (10.1016/j.vaccine.2016.10.024_b0115) 2002; 24
Fleming (10.1016/j.vaccine.2016.10.024_b0130) 2006; 25
el-Madhun (10.1016/j.vaccine.2016.10.024_b0170) 1998; 178
References_xml – volume: 60
  start-page: 661
  year: 2012
  end-page: 666
  ident: b0010
  article-title: Differential serum cytokine responses to inactivated and live attenuated seasonal influenza vaccines
  publication-title: Cytokine
– volume: 69
  start-page: 531
  year: 2000
  end-page: 569
  ident: b0110
  article-title: Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin
  publication-title: Annu Rev Biochem
– volume: 31
  start-page: 430
  year: 2011
  end-page: 435
  ident: b0120
  article-title: Aging affects human B cell responses
  publication-title: J Clin Immunol
– volume: 10
  start-page: 14
  year: 2013
  ident: b0030
  article-title: Effects of age on H1N1-specific serum IgG1 and IgG3 levels evaluated during the 2011–2012 influenza vaccine season
  publication-title: Immun Ageing
– volume: 19
  start-page: 217
  year: 2000
  end-page: 226
  ident: b0175
  article-title: Safety and immunogenicity of adjuvanted and unadjuvanted subunit influenza vaccines administered intranasally to healthy adults
  publication-title: Vaccine
– volume: 178
  start-page: 1030
  year: 2007
  end-page: 1038
  ident: b0140
  article-title: Priming with cold-adapted influenza A does not prevent infection but elicits long-lived protection against supralethal challenge with heterosubtypic virus
  publication-title: J Immunol
– volume: 40
  start-page: 1044
  year: 1983
  end-page: 1051
  ident: b0095
  article-title: Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus
  publication-title: Infect Immun
– volume: 82
  start-page: 1387
  year: 2001
  end-page: 1395
  ident: b0105
  article-title: A haemagglutinin (HA1)-specific FAb neutralizes influenza A virus by inhibiting fusion activity
  publication-title: J Gen Virol
– volume: 178
  start-page: 933
  year: 1998
  ident: b0170
  article-title: Systemic and mucosal immune responses in young children and adults after parenteral influenza vaccination
  publication-title: J Infect Dis
– volume: 32
  start-page: 4550
  year: 2014
  end-page: 4557
  ident: b0085
  article-title: Serum IgG titres, but not avidity, correlates with neutralizing antibody response after H5N1 vaccination
  publication-title: Vaccine
– volume: 30
  start-page: 6794
  year: 2012
  end-page: 6801
  ident: b0150
  article-title: The role of nasal IgA in children vaccinated with live attenuated influenza vaccine
  publication-title: Vaccine
– volume: 25
  year: 2014
  ident: b0190
  article-title: Longevity of B-cell and T-cell responses after live attenuated influenza vaccination in children
  publication-title: J Infect Dis
– volume: 207
  start-page: 115
  year: 2013
  end-page: 124
  ident: b0180
  article-title: Localized mucosal response to intranasal live attenuated influenza vaccine in adults
  publication-title: J Infect Dis
– volume: 24
  start-page: 157
  year: 1986 Jul
  end-page: 160
  ident: b0055
  article-title: Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus
  publication-title: J Clin Microbiol
– volume: 180
  start-page: 1356
  year: 1999
  ident: b0070
  article-title: The effect of age and natural priming on the IgG and IgA subclass responses after parenteral influenza vaccination
  publication-title: J Infect Dis
– volume: 24
  start-page: 1159
  year: 2006
  ident: b0020
  article-title: Antibody response to influenza vaccination in the elderly: a quantitative review
  publication-title: Vaccine
– volume: 25
  start-page: 4056
  year: 2007
  end-page: 4063
  ident: b0050
  article-title: Comparison of neutralising antibody assays for detection of antibody to influenza A/H3N2 viruses: an international collaborative study
  publication-title: Vaccine
– volume: 136
  start-page: 168
  year: 2000
  end-page: 175
  ident: b0155
  article-title: Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine
  publication-title: J Pediatr
– volume: 11
  start-page: e1004940
  year: 2015
  ident: b0005
  article-title: Geometric constraints dominate the antigenic evolution of influenza H3N2 hemagglutinin
  publication-title: PLoS Pathog
– volume: 171
  start-page: 198
  year: 1995
  ident: b0165
  article-title: Parenteral influenza vaccination induces a rapid systemic and local immune response
  publication-title: J Infect Dis
– volume: 57
  start-page: 236
  year: 2004
  ident: b0075
  article-title: Defense mechanisms against influenza virus infection in the respiratory tract mucosa
  publication-title: Jpn J Infect Dis
– volume: 25
  start-page: 870
  year: 2006
  end-page: 879
  ident: b0125
  article-title: Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections
  publication-title: Pediatr Infect Dis J
– volume: 26
  start-page: 4940
  year: 2008
  end-page: 4946
  ident: b0160
  article-title: Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5–49
  publication-title: Vaccine
– volume: 9
  start-page: 669
  year: 2011
  end-page: 683
  ident: b0035
  article-title: Serologic assays for influenza surveillance, diagnosis and vaccine evaluation
  publication-title: Expert Rev Anti-Infect
– volume: 154
  start-page: 121
  year: 1986
  end-page: 127
  ident: b0185
  article-title: Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine
  publication-title: J Infect Dis
– volume: 25
  start-page: 860
  year: 2006
  end-page: 869
  ident: b0130
  article-title: Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma
  publication-title: Pediatr Infect Dis J
– volume: 52
  start-page: 1
  year: 1975
  ident: b0040
  article-title: Single-radial-haemolysis: a new method for the assay of antibody to influenza haemagglutinin: applications for diagnosis and seroepidemiologic surveillance of influenza
  publication-title: Bull World Health Organ
– volume: 29
  start-page: 266
  year: 2010
  end-page: 273
  ident: b0080
  article-title: An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers
  publication-title: Vaccine
– reference: Organization WH. Influenza (seasonal) factsheet 211; 2014. Available from:
– volume: 177
  start-page: 1112
  year: 1998 Apr
  end-page: 1115
  ident: b0195
  article-title: Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization
  publication-title: J Infect Dis
– volume: 14
  start-page: 2906
  year: 2014
  end-page: 2913
  ident: b0090
  article-title: Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)-United States, 2014–15 influenza season
  publication-title: Am J Transplant
– volume: 125
  start-page: S41
  year: 2010
  end-page: S52
  ident: b0065
  article-title: Structure and function of immunoglobulins
  publication-title: J Allergy Clin Immunol
– volume: 23
  start-page: 66
  year: 1986
  end-page: 72
  ident: b0100
  article-title: Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine
  publication-title: J Clin Microbiol
– volume: 24
  start-page: 193
  year: 2002
  end-page: 201
  ident: b0115
  article-title: The humoral response to live and inactivated influenza vaccines administered alone and in combination to young adults and elderly
  publication-title: J Clin Virol
– reference: .
– volume: 58
  start-page: 319
  year: 2014
  end-page: 327
  ident: b0025
  article-title: Influenza vaccine effectiveness in the 2011–2012 season: protection against each circulating virus and the effect of prior vaccination on estimates
  publication-title: Clin Infect Dis
– volume: 33
  start-page: 4146
  year: 2015
  end-page: 4154
  ident: b0200
  article-title: Persistence and avidity maturation of antibodies to A(H1N1)pdm09 in healthcare workers following repeated annual vaccinations
  publication-title: Vaccine
– volume: 168
  start-page: 135
  year: 2012
  end-page: 141
  ident: b0060
  article-title: Immunoglobulin G subclass levels and antibody responses to the 2009 influenza A (H1N1) monovalent vaccine among human immunodeficiency virus (HIV)-infected and HIV-uninfected adults
  publication-title: Clin Exp Immunol
– volume: 18
  start-page: 899
  year: 1999
  end-page: 906
  ident: b0135
  article-title: Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses
  publication-title: Vaccine
– volume: 208
  start-page: 594
  year: 2013
  end-page: 602
  ident: b0145
  article-title: Evaluation of the humoral and cellular immune responses elicited by the live attenuated and inactivated influenza vaccines and their roles in heterologous protection in ferrets
  publication-title: J Infect Dis
– volume: 422
  start-page: 95
  year: 2015
  end-page: 101
  ident: b0045
  article-title: Validation of Single Radial Haemolysis assay: a reliable method to measure antibodies against influenza viruses
  publication-title: J Immunol Methods
– volume: 31
  start-page: 430
  issue: 3
  year: 2011
  ident: 10.1016/j.vaccine.2016.10.024_b0120
  article-title: Aging affects human B cell responses
  publication-title: J Clin Immunol
  doi: 10.1007/s10875-010-9501-7
– volume: 154
  start-page: 121
  issue: 1
  year: 1986
  ident: 10.1016/j.vaccine.2016.10.024_b0185
  article-title: Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine
  publication-title: J Infect Dis
  doi: 10.1093/infdis/154.1.121
– volume: 178
  start-page: 933
  issue: 4
  year: 1998
  ident: 10.1016/j.vaccine.2016.10.024_b0170
  article-title: Systemic and mucosal immune responses in young children and adults after parenteral influenza vaccination
  publication-title: J Infect Dis
  doi: 10.1086/515656
– volume: 422
  start-page: 95
  issue: July
  year: 2015
  ident: 10.1016/j.vaccine.2016.10.024_b0045
  article-title: Validation of Single Radial Haemolysis assay: a reliable method to measure antibodies against influenza viruses
  publication-title: J Immunol Methods
  doi: 10.1016/j.jim.2015.04.009
– volume: 29
  start-page: 266
  issue: 2
  year: 2010
  ident: 10.1016/j.vaccine.2016.10.024_b0080
  article-title: An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2010.10.038
– volume: 180
  start-page: 1356
  issue: 4
  year: 1999
  ident: 10.1016/j.vaccine.2016.10.024_b0070
  article-title: The effect of age and natural priming on the IgG and IgA subclass responses after parenteral influenza vaccination
  publication-title: J Infect Dis
  doi: 10.1086/315003
– volume: 69
  start-page: 531
  year: 2000
  ident: 10.1016/j.vaccine.2016.10.024_b0110
  article-title: Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin
  publication-title: Annu Rev Biochem
  doi: 10.1146/annurev.biochem.69.1.531
– volume: 25
  start-page: 870
  issue: 10
  year: 2006
  ident: 10.1016/j.vaccine.2016.10.024_b0125
  article-title: Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections
  publication-title: Pediatr Infect Dis J
  doi: 10.1097/01.inf.0000237829.66310.85
– volume: 208
  start-page: 594
  issue: 4
  year: 2013
  ident: 10.1016/j.vaccine.2016.10.024_b0145
  article-title: Evaluation of the humoral and cellular immune responses elicited by the live attenuated and inactivated influenza vaccines and their roles in heterologous protection in ferrets
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jit207
– volume: 11
  start-page: e1004940
  issue: 5
  year: 2015
  ident: 10.1016/j.vaccine.2016.10.024_b0005
  article-title: Geometric constraints dominate the antigenic evolution of influenza H3N2 hemagglutinin
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1004940
– volume: 18
  start-page: 899
  issue: 9–10
  year: 1999
  ident: 10.1016/j.vaccine.2016.10.024_b0135
  article-title: Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses
  publication-title: Vaccine
  doi: 10.1016/S0264-410X(99)00334-5
– volume: 60
  start-page: 661
  issue: 3
  year: 2012
  ident: 10.1016/j.vaccine.2016.10.024_b0010
  article-title: Differential serum cytokine responses to inactivated and live attenuated seasonal influenza vaccines
  publication-title: Cytokine
  doi: 10.1016/j.cyto.2012.08.004
– volume: 58
  start-page: 319
  issue: 3
  year: 2014
  ident: 10.1016/j.vaccine.2016.10.024_b0025
  article-title: Influenza vaccine effectiveness in the 2011–2012 season: protection against each circulating virus and the effect of prior vaccination on estimates
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/cit736
– volume: 82
  start-page: 1387
  issue: June
  year: 2001
  ident: 10.1016/j.vaccine.2016.10.024_b0105
  article-title: A haemagglutinin (HA1)-specific FAb neutralizes influenza A virus by inhibiting fusion activity
  publication-title: J Gen Virol
  doi: 10.1099/0022-1317-82-6-1387
– volume: 26
  start-page: 4940
  issue: 38
  year: 2008
  ident: 10.1016/j.vaccine.2016.10.024_b0160
  article-title: Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5–49years of age
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2008.07.013
– volume: 33
  start-page: 4146
  issue: 33
  year: 2015
  ident: 10.1016/j.vaccine.2016.10.024_b0200
  article-title: Persistence and avidity maturation of antibodies to A(H1N1)pdm09 in healthcare workers following repeated annual vaccinations
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2015.05.081
– volume: 30
  start-page: 6794
  issue: 48
  year: 2012
  ident: 10.1016/j.vaccine.2016.10.024_b0150
  article-title: The role of nasal IgA in children vaccinated with live attenuated influenza vaccine
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2012.09.018
– volume: 19
  start-page: 217
  issue: 2–3
  year: 2000
  ident: 10.1016/j.vaccine.2016.10.024_b0175
  article-title: Safety and immunogenicity of adjuvanted and unadjuvanted subunit influenza vaccines administered intranasally to healthy adults
  publication-title: Vaccine
  doi: 10.1016/S0264-410X(00)00171-7
– volume: 125
  start-page: S41
  issue: 2
  year: 2010
  ident: 10.1016/j.vaccine.2016.10.024_b0065
  article-title: Structure and function of immunoglobulins
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2009.09.046
– volume: 52
  start-page: 1
  issue: 1
  year: 1975
  ident: 10.1016/j.vaccine.2016.10.024_b0040
  article-title: Single-radial-haemolysis: a new method for the assay of antibody to influenza haemagglutinin: applications for diagnosis and seroepidemiologic surveillance of influenza
  publication-title: Bull World Health Organ
– volume: 177
  start-page: 1112
  issue: 4
  year: 1998
  ident: 10.1016/j.vaccine.2016.10.024_b0195
  article-title: Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization
  publication-title: J Infect Dis
  doi: 10.1086/517407
– volume: 24
  start-page: 193
  issue: 3
  year: 2002
  ident: 10.1016/j.vaccine.2016.10.024_b0115
  article-title: The humoral response to live and inactivated influenza vaccines administered alone and in combination to young adults and elderly
  publication-title: J Clin Virol
  doi: 10.1016/S1386-6532(01)00246-3
– volume: 40
  start-page: 1044
  issue: 3
  year: 1983
  ident: 10.1016/j.vaccine.2016.10.024_b0095
  article-title: Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus
  publication-title: Infect Immun
  doi: 10.1128/IAI.40.3.1044-1051.1983
– volume: 32
  start-page: 4550
  issue: 35
  year: 2014
  ident: 10.1016/j.vaccine.2016.10.024_b0085
  article-title: Serum IgG titres, but not avidity, correlates with neutralizing antibody response after H5N1 vaccination
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2014.06.009
– volume: 24
  start-page: 1159
  issue: 8
  year: 2006
  ident: 10.1016/j.vaccine.2016.10.024_b0020
  article-title: Antibody response to influenza vaccination in the elderly: a quantitative review
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2005.08.105
– volume: 23
  start-page: 66
  issue: 1
  year: 1986
  ident: 10.1016/j.vaccine.2016.10.024_b0100
  article-title: Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.23.1.66-72.1986
– volume: 24
  start-page: 157
  issue: 1
  year: 1986
  ident: 10.1016/j.vaccine.2016.10.024_b0055
  article-title: Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.24.1.157-160.1986
– volume: 136
  start-page: 168
  issue: 2
  year: 2000
  ident: 10.1016/j.vaccine.2016.10.024_b0155
  article-title: Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine
  publication-title: J Pediatr
  doi: 10.1016/S0022-3476(00)70097-7
– volume: 10
  start-page: 14
  issue: 1
  year: 2013
  ident: 10.1016/j.vaccine.2016.10.024_b0030
  article-title: Effects of age on H1N1-specific serum IgG1 and IgG3 levels evaluated during the 2011–2012 influenza vaccine season
  publication-title: Immun Ageing
  doi: 10.1186/1742-4933-10-14
– volume: 178
  start-page: 1030
  issue: 2
  year: 2007
  ident: 10.1016/j.vaccine.2016.10.024_b0140
  article-title: Priming with cold-adapted influenza A does not prevent infection but elicits long-lived protection against supralethal challenge with heterosubtypic virus
  publication-title: J Immunol
  doi: 10.4049/jimmunol.178.2.1030
– volume: 171
  start-page: 198
  year: 1995
  ident: 10.1016/j.vaccine.2016.10.024_b0165
  article-title: Parenteral influenza vaccination induces a rapid systemic and local immune response
  publication-title: J Infect Dis
  doi: 10.1093/infdis/171.1.198
– volume: 9
  start-page: 669
  issue: 6
  year: 2011
  ident: 10.1016/j.vaccine.2016.10.024_b0035
  article-title: Serologic assays for influenza surveillance, diagnosis and vaccine evaluation
  publication-title: Expert Rev Anti-Infect
  doi: 10.1586/eri.11.51
– volume: 25
  start-page: 4056
  issue: 20
  year: 2007
  ident: 10.1016/j.vaccine.2016.10.024_b0050
  article-title: Comparison of neutralising antibody assays for detection of antibody to influenza A/H3N2 viruses: an international collaborative study
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2007.02.039
– volume: 207
  start-page: 115
  issue: 1
  year: 2013
  ident: 10.1016/j.vaccine.2016.10.024_b0180
  article-title: Localized mucosal response to intranasal live attenuated influenza vaccine in adults
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jis641
– ident: 10.1016/j.vaccine.2016.10.024_b0015
– volume: 168
  start-page: 135
  issue: 1
  year: 2012
  ident: 10.1016/j.vaccine.2016.10.024_b0060
  article-title: Immunoglobulin G subclass levels and antibody responses to the 2009 influenza A (H1N1) monovalent vaccine among human immunodeficiency virus (HIV)-infected and HIV-uninfected adults
  publication-title: Clin Exp Immunol
  doi: 10.1111/j.1365-2249.2011.04550.x
– volume: 25
  start-page: 860
  issue: 10
  year: 2006
  ident: 10.1016/j.vaccine.2016.10.024_b0130
  article-title: Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma
  publication-title: Pediatr Infect Dis J
  doi: 10.1097/01.inf.0000237797.14283.cf
– volume: 57
  start-page: 236
  issue: 6
  year: 2004
  ident: 10.1016/j.vaccine.2016.10.024_b0075
  article-title: Defense mechanisms against influenza virus infection in the respiratory tract mucosa
  publication-title: Jpn J Infect Dis
  doi: 10.7883/yoken.JJID.2004.236
– volume: 14
  start-page: 2906
  issue: 12
  year: 2014
  ident: 10.1016/j.vaccine.2016.10.024_b0090
  article-title: Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)-United States, 2014–15 influenza season
  publication-title: Am J Transplant
  doi: 10.1111/ajt.13065
– volume: 25
  issue: November
  year: 2014
  ident: 10.1016/j.vaccine.2016.10.024_b0190
  article-title: Longevity of B-cell and T-cell responses after live attenuated influenza vaccination in children
  publication-title: J Infect Dis
SSID ssj0005319
Score 2.3286202
Snippet •LAIV3 induced age-related hemagglutination inhibition antibody responses.•IgG1 was the main IgG subclass detected followed by IgG3.•Significant...
Highlights • LAIV3 induced age-related hemagglutination inhibition antibody responses. • IgG1 was the main IgG subclass detected followed by IgG3. •...
Two different influenza vaccines are generally used in many countries; trivalent live attenuated influenza vaccine (LAIV3) and trivalent inactivated influenza...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 191
SubjectTerms Administration, Intranasal
Adolescent
Adult
adults
Age
Age Factors
Allergy and Immunology
antibodies
Antibodies, Viral - blood
Antibody Affinity
Antibody Formation
Antibody response
Child
Child, Preschool
children
Enzyme-Linked Immunosorbent Assay
Female
Health care
Hemagglutination Inhibition Tests
Hemagglutinin Glycoproteins, Influenza Virus - immunology
hemagglutinins
Humans
humoral immunity
IgA
IgG subclass
Immunization
immunoglobulin A
Immunoglobulin A - blood
immunoglobulin G
Immunoglobulin G - blood
Immunoglobulins
Infections
Influenza
Influenza A virus
Influenza A Virus, H3N2 Subtype - immunology
Influenza Vaccines - administration & dosage
Influenza Vaccines - immunology
Injections, Intramuscular
LAIV3
Live attenuated influenza vaccine
Male
Medical personnel
Middle Aged
Regulatory approval
Studies
vaccination
Vaccines
Vaccines, Attenuated - administration & dosage
Vaccines, Attenuated - immunology
Vaccines, Inactivated - administration & dosage
Vaccines, Inactivated - immunology
viruses
Young Adult
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Rb9MwELZgCMTLBAVGxkBGQhNIS5fEjpM8oWpiFKRNk9hQ3izHiatOKB1NO2n8En4ud46T8MA6XmOfHeXO58_x3XeEvEu1TnihmG-YMD5nUeWrWJW-MYqrMi0EszyzJ6diesG_5nHufrg1Lqyy84nWUZcLjf_ID-EkglRZWZh-vPrpY9UovF11JTTukweWugzsOcmTIcSD2cIecMzgPg-DfMjgObwcXyuNV9cY3SXGGOAV8dv2ptuwp92Djp-QbQce6aTV9lNyr6pH5GFbTvJmRB6duIvyEdk_aympbw7o-ZBh1RzQfXo2kFWDzOg7xsPYpFzaiT8jv48GUnCqHG8JXRg6b2ua_FJ08n7KTqMP9Hq-XDcUqV9nM7Tiel5TTN_EECT6ZfaZNutCI0SHcUp4MKHLNiy3amA02iWT21ZLBgIdsW75X1O139Ca0HNycfzp_GjquxoOvgastPJjUaqiMJylOjWBCkSgokgniSpFWgoTFxnH1FhAKTrTBZbUiyMN26kyWgiVKfaCbNWLunpJKPgWoUVWccMFD0OlitSkQVKUgAhZwJVHeKc9qR3BOdbZ-CG7SLZL6ZQuUen4GJTukXEvdtUyfNwlIDrTkF36KjhcCXvQXYLJvwSrxrmNRoayiWQgvwUWpgY5gGXkN8w8kvaSDhm1iOd_Jt3rrFcO8_SLySNv-2ZwLHhbpOpqscY-LBYZnJb5hj4Z0h3CiXlDH8wFi2JkVfLITrt6-u8cJUkKU8S7m1_yFXkcIZqy0X97ZGu1XFevAQuuijd2wf8BVrle0w
  priority: 102
  providerName: ProQuest
Title Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0264410X16309409
https://www.clinicalkey.es/playcontent/1-s2.0-S0264410X16309409
https://dx.doi.org/10.1016/j.vaccine.2016.10.024
https://www.ncbi.nlm.nih.gov/pubmed/27789145
https://www.proquest.com/docview/1846812918
https://www.proquest.com/docview/1835691484
https://www.proquest.com/docview/1906459664
https://www.proquest.com/docview/2000252357
Volume 35
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELa2TiBeEBQYhYGMhCaQlja1Hcd5LNVGB1pVwYb6ZjlOXHVC6dS0k8YDfwd_Lnf50YBgG-IliZy7uLWduy_y3XeEvFbWhiI23HNcOk9wlnomMInnnBEmUbHkBc_syViOzsSHaTDdIsM6FwbDKivbX9r0wlpXLb1qNHsX83nvs1_4cn8KiAJJ4KJtssN4JIMW2RkcfxyNm0gPXtT3QHkPFZpEnt5599JY3MHGIC_ZxTgvJq5zUddB0MIVHT0g9ysMSQflz3xIttKsTe6UVSWv2uTuSbVf3ib7k5KZ-uqAnjaJVvkB3aeThrMadNpfMCymyM2ltfoj8mPYcINTU9GX0IWj87K0yTdDB29GfMze0sv5cp1TZICdzXAxZ_OMYhYnRiLR49l7mq9ji0gdnpNAw4Auy-jcNIen0TqnvLhbcIKAIJYv_6WrcgyLlfSYnB0dng5HXlXKwbMAmVZeIBMTx05wZZXzjS99w5gNQ5NIlUgXxJHADFkAKzayMVbWC5gFr2qcldJEhj8hrWyRpU8JBRMjrYxS4YQU_b4xsXLKD-MEgCH3hekQUc-ethXPOZbb-KrrgLZzXU26xknHZpj0Dulu1C5Koo_bFGS9NHSdxQp2V4Mruk0x_JtimlfWI9d9nTPt6z9WeIeojeZvL8m_dLpXr17d9APgEwBe1Fcd8mpzG-wLbhqZLF2sUYYHMoKPZnGDTISsh_DhfIMMpoSxAMmVOmS3fHs248zCUEEXwbP__3_PyT2GgKsIENwjrdVynb4AuLiKX5Lt7vc-HMNpCEc1hOvSQMD53eF48ukn3ZVukw
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGJz5eEJSvwgAjwQTS0qWO4yQPCJWx0bK1qkaH-mYcJ646oXQ07VD5S_gr-Bu5y0fDA-t42Wvis6vc-XxX3-93hLz0tfZ4qBzLOMJY3GGxpVwVWcYoriI_FE7GM9vri84J_zRyRxvkd4mFwbLK0idmjjqaavyPfBcyEaTKClr-u7PvFnaNwtvVsoVGbhaH8fIHpGzp2-4H0O8rxg72h3sdq-gqYGk4veeWKyIVhoY7vvaNrWxhK8a056lI-JEwbhhwBGvCuakDHWKTN5dpcPDKaCFUoByY9xrZ5IhorZHN9_v9wXFVVOJkrUQgseEWb9mjCjO0e9o8Vxovy7GeTDSxpIzxi07Di6Ld7NQ7uENuF-Eqbef2dZdsxEmdXM8bWC7r5EavuJqvk-1BToK93KHDCtOV7tBtOqjosUGm_gUrcDIYMC3F75FfexUNOVUFUwqdGjrJu6j8VLT9uuP02Rt6PpktUopks-Mx7ptkklAEjGLRE-2OP9J0EWpMCmCeCB606SwvBI5TmI2W8PXsbUY_AgOxU_pfS-XfMDPa--TkSvT7gNSSaRI_IhS8mdAiiLnhgrdaSoW-8W0vjCAGdWyuGoSX2pO6oFTHzh7fZFk7dyoLpUtUOj4GpTdIcyV2lnOKXCYgStOQJWAWXLyEU-8yQe9fgnFaOKpUtmTKpC0_21lgbI8gPEdGxaBB_JVkEYvlMdb_LLpVWq-s1llt3wZ5sXoNrgzvp1QSTxc4xnFFAPk5XzMmQIJFyNHXjEH0GXORx6lBHua7Z_Wdmef5sIT7eP2PfE5udoa9I3nU7R8-IbcYxnJZ7eEWqc1ni_gpRKLz8Fmx_Sn5etUe5w9Gy5zU
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLbGEBMvCMqtMMBIMIG0tKntOMkDQtVGWRmrKrFNfTOOE1edUDqadqj8En4Lv45zcml4YB0ve0187CrnXp_zHUJeBcb4ItLcsVxaR3CWONrTsWOtFjoOIslznNmjgTw4EZ9G3miD_K56YbCssrKJuaGOpwb_I29DJoJQWWEnaNuyLGK433t__t3BCVJ401qN0yhE5DBZ_oD0LXvX3wdev2as9-F478ApJww4Bjz53PFkrKPICh6YwLrala5mzPi-jmUQS-tFocDGTfChJjQRDnzzmAFjr62RUoeaw743yE2fQ1QFuuSP_Lq8hOdDRSDFEY7ouKO6e6h91rrQBq_NsbJMtrC4jInL_OJlcW_u_3p3yZ0ycKXdQtLukY0kbZBbxSjLZYNsHZWX9A2yMyzgsJe79Lju7sp26Q4d1kDZQNM4xVqcvCGYVuT3ya-9GpCc6hIzhU4tnRTzVH5q2n1zwAfsLb2YzBYZRdjZ8Rg1KJ2kFFtHsfyJ9scfabaIDKYHsE8MD7p0VpQEJxnsRqtG9vxtDkQCC3Fm-l9HFd8wF98H5ORauPuQbKbTNHlMKNg1aWSYCCuk6HS0jgIbuH4UQzTKXaGbRFTcU6YEV8cZH99UVUV3pkqmK2Q6PgamN0lrRXZeoItcRSAr0VBV6ywYewX-7ypC_1-ESVaarEx1VMaUq764eYjsjiBQR2zFsEmCFWUZlRXR1v8cul1Jr6rPWSlyk7xcvQajhjdVOk2mC1zDPRlCpi7WrAkRahGy9TVrsA-NeYjo1CSPCu1ZfWfm-wEc4T1Z_yNfkC2wM-pzf3D4lNxmGNTlRYjbZHM-WyTPICSdR89z3afk63Ubmz-UfZ-b
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparative+analysis+of+influenza+A%28H3N2%29+virus+hemagglutinin+specific+IgG+subclass+and+IgA+responses+in+children+and+adults+after+influenza+vaccination&rft.jtitle=Vaccine&rft.au=Manenti%2C+Alessandro&rft.au=Tete%2C+Sarah+M.&rft.au=Mohn%2C+Kristin+G.-I.&rft.au=Jul-Larsen%2C+%C3%85sne&rft.date=2017-01-03&rft.pub=Elsevier+Ltd&rft.issn=0264-410X&rft.volume=35&rft.issue=1&rft.spage=191&rft.epage=198&rft_id=info:doi/10.1016%2Fj.vaccine.2016.10.024&rft.externalDocID=S0264410X16309409
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F0264410X%2FS0264410X16X00539%2Fcov150h.gif